PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Launched by TULANE UNIVERSITY · Apr 8, 2021

Keywords

ClinConnect Summary

This clinical trial is exploring how well a device called Photoplethysmography (PPG) can help predict the heart's ejection fraction (EF) and other heart-related measurements seen in echocardiograms, which are tests that use sound waves to look at the heart. Researchers want to understand if the signals from PPG can provide useful information about heart conditions like valvular heart disease, pericardial disease, and other heart muscle issues. The trial is currently looking for participants who are at least 18 years old and are scheduled to get an echocardiogram at Tulane Medical Center.

If you join this study, you'll wear a small device called a Biostrap during your echocardiogram, which will help collect the data needed for the research. It's important to note that people who are under 18, have trouble understanding English, or cannot physically wear the Biostrap won't be eligible to participate. This study is a great opportunity to contribute to our understanding of heart health and how new technology can help in diagnosing heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or Female aged18 years or older.
• • Patients scheduled to undergo an echocardiogram at Tulane Medical Center.
• Exclusion Criteria:
• • Participants under 18 years of age.
• • Participants with cognitive impairments.
• • Participants with a physical inability to wear the Biostrap during the echocardiogram.
• • Individuals who cannot read, speak, and/or understand English.